Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FDJH6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,365
Award facts
- Contract value 100% obligated
- $12,364.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg on December 22, 2025, with an ultimate completion date of December 23, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply solutions to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc., registered in the System for Award Management since 2001, serves as a critical pharmaceutical supplier within the federal military medical supply chain. The company's broader PPV-G GEN V IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. Through this vehicle, the company supplies an extensive portfolio including branded and generic prescription medications, biologics, vaccines, oncology treatments, and medical consumables to support recurring medical supply needs across the Department of Defense healthcare system globally.
Quick answers
Who was awarded contract SPE2DR26FDJH6?
SPE2DR26FDJH6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FDJH6 worth?
The government has obligated $12,365 on SPE2DR26FDJH6.
Is contract SPE2DR26FDJH6 an order under another contract?
Yes. SPE2DR26FDJH6 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJH6 competed?
The extent of competition for SPE2DR26FDJH6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award